Literature DB >> 23050704

Open ankle dislocations without associated fracture.

Bekir Yavuz Uçar1, Serdar Necmioğlu, Mehmet Bulut, Ibrahim Azboy, Abdullah Demirtaş.   

Abstract

BACKGROUND: This study aimed to clarify the intermediate followup results of reduction without soft tissue repair in open ankle dislocations without fracture.
METHODS: We retrospectively reviewed cases of open isolated ankle dislocations without associated fracture. Five male patients treated between January 2005 and July 2009 were enrolled in this study. Debridement and reduction with primary wound closure of the skin were performed without suture of the capsule or repair of the ligaments. The outcome was evaluated by the American Orthopaedic Foot & Ankle Society score (AOFAS). The time period for returning to previous level of activity was also recorded.
RESULTS: The average age of the patients was 34 (range, 27 to 44) years, and the average followup was 4 (range, 2 to 6) years. The average of the last control AOFAS score was 90 (range, 84 to 98) points. Two ankles were rated as excellent, and the other three were rated as good. Patients returned to their previous levels of physical activity at an average of 9 weeks.
CONCLUSION: Favorable long-term results were obtained for reduction without ligament repair in pure ankle dislocations.

Entities:  

Mesh:

Year:  2012        PMID: 23050704     DOI: 10.3113/FAI.2012.0828

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  2 in total

1.  Pure Ankle Dislocation Without Associated Fracture: A Series of Cases and Our Clinical Experience.

Authors:  Ting-Jiang Gan; Ya-Xing Li; Xi Liu; Hui Zhang
Journal:  Indian J Orthop       Date:  2022-06-27       Impact factor: 1.033

2.  Treatment of open ankle dislocation without associated fractures in a young athlete using external fixation and ligament repair with suture tape augmentation.

Authors:  Ryosuke Kawai; Itaru Kawashima; Makoto Tsukada; Takashi Tsukahara; Hideyuki Aoshiba
Journal:  BMC Musculoskelet Disord       Date:  2020-06-05       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.